Literature DB >> 4627543

Leukocyte kininogenases and leukokinins from normal and malignant cells.

L M Greenbaum.   

Abstract

Mesh：

Substances：

Year:  1972        PMID： 4627543      PMCID： PMC2032760     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  12 in total

1.  The inhibition of tissue acid proteinases by pepstatin.

Authors:  A J Barrett; J T Dingle
Journal:  Biochem J       Date:  1972-04       Impact factor: 3.857

2.  The physiological role of the lymphoid system. VI. The stimulatory effect of leucophilic gamma globulin (leucokinin) on the phagocytic activity of human polymorphonuclear leucocyte.

Authors:  B V Fidalgo; V A Najjar
Journal:  Biochemistry       Date:  1967-11       Impact factor: 3.162

3.  Pepstatin, a new pepsin inhibitor produced by Actinomycetes.

Authors:  H Umezawa; T Aoyagi; H Morishima; M Matsuzaki; M Hamada
Journal:  J Antibiot (Tokyo)       Date:  1970-05       Impact factor: 2.649

4.  The kinin-forming and kininase activities of rabbit polymorphonuclear leucocytes.

Authors:  L M Greenbaum; K S Kim
Journal:  Br J Pharmacol Chemother       Date:  1967-02

5.  The inflammatory reaction in chemical injury. 3. Leucocytosis and other histological changes induced by superficial injury.

Authors:  R H Steele; D L Wilhelm
Journal:  Br J Exp Pathol       Date:  1970-06

6.  The generation of kinins in the blood of dogs during hypotension due to haemorrhage.

Authors:  H E Berry; J G Collier; J R Vane
Journal:  Clin Sci       Date:  1970-09       Impact factor: 6.124

7.  Kinin-forming activity of human lymphocytes.

Authors:  E G Engleman; L M Greenbaum
Journal:  Biochem Pharmacol       Date:  1971-04       Impact factor: 5.858

8.  PMN-kinin and kinin metabolizing enzymes in normal and malignant leucocytes.

Authors:  L M Greenbaum; R Freer; J Chang; G Semente; K Yamafuji
Journal:  Br J Pharmacol       Date:  1969-07       Impact factor: 8.739

9.  Polymorphonuclear leukocytes in immunologic reactions. The destruction of vascular basement membrane in vivo and in vitro.

Authors:  C G Cochrane; B S Aikin
Journal:  J Exp Med       Date:  1966-10-01       Impact factor: 14.307

10.  The isolation and properties of the specific cytoplasmic granules of rabbit polymorphonuclear leucocytes.

Authors:  Z A COHN; J G HIRSCH
Journal:  J Exp Med       Date:  1960-12-01       Impact factor: 14.307
View more
  8 in total

1.  Leukokinin-H generated from human ascites fluid; its isolation and pharmacology.

Authors:  P Grebow; A Prakash; L M Greenbaum
Journal:  Agents Actions       Date:  1979-08

2.  Studies on the mechanism of endogenous pyrogen production. II. Role of cell products in the regulation of pyrogen release from blood leukocytes.

Authors:  P Bodel
Journal:  Infect Immun       Date:  1974-09       Impact factor: 3.441

3.  The leukokinin system; its role in fluid accumulation in malignancy and inflammation.

Authors:  L M Greenbaum; A Prakash; G Semente; M Johnston
Journal:  Agents Actions       Date:  1973-12

4.  Pathologic mechanisms in neutrophil-mediated injury.

Authors:  P M Henson
Journal:  Am J Pathol       Date:  1972-09       Impact factor: 4.307

Review 5.  Acute inflammation. A review.

Authors:  G B Ryan; G Majno
Journal:  Am J Pathol       Date:  1977-01       Impact factor: 4.307

6.  Haemorrhagic and inflammatory properties of collagenase from C. histolyticum.

Authors:  B B Vargaftig; J Lefort; E L Giroux
Journal:  Agents Actions       Date:  1976-09

7.  Effects of protizinic acid on leukokinin generation and its physiological action.

Authors:  K Suzuki; T Niho; K Yamaguchi; H Ohnishi
Journal:  Agents Actions       Date:  1984-06

8.  The biochemistry of lymphocyte-derived mediators of immunological inflammation.

Authors:  J C Houck; K B Hellman; C M Chang
Journal:  Agents Actions       Date:  1978-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.